{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:29:52Z","timestamp":1794497392402,"version":"4.9.1"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,26]]},"abstract":"<jats:p>Guillain-Barr\u00e9 Syndrome (GBS) is a rare but potentially life-threatening neurological disorder characterized by acute onset ascending paralysis and sensory abnormalities. This article provides a comprehensive overview of GBS, covering its epidemiology, etiology, clinical presentation, diagnostic evaluation, management and treatment, prognosis, psychosocial impact, recent advances in research, public health implications, and ethical considerations. Epidemiological data reveal variations in GBS prevalence, incidence rates, and geographical distribution influenced by climate, infectious disease prevalence, and genetic susceptibility. Etiological factors include preceding infections, vaccinations, and autoimmune mechanisms, although the precise pathophysiology remains incomplete. Clinical presentation encompasses prodromal symptoms, motor deficits, sensory abnormalities, autonomic dysfunction, and variants such as Miller-Fisher Syndrome and Bickerstaff brainstem encephalitis. Neurological examination findings include weakness, paralysis, sensory deficits, and reflex changes, while autonomic dysfunction manifests as cardiovascular, respiratory, and gastrointestinal symptoms. Diagnostic evaluation relies on clinical criteria, laboratory tests (e.g., cerebrospinal fluid analysis, nerve conduction studies), and consideration of differential diagnoses. Management strategies encompass supportive care, immunomodulatory therapies (e.g., intravenous immunoglobulin, plasma exchange), and rehabilitation interventions to optimize functional outcomes and promote recovery. Prognosis varies depending on clinical features, treatment response, and complications such as respiratory failure and autonomic instability. Psychosocial impact encompasses psychological effects on patients and caregivers, highlighting the importance of coping strategies and support systems. Recent advances in research focus on emerging treatments, genetic predisposition, and biomarker discovery, offering promise for improving GBS outcomes. Public health implications include vaccination safety concerns and healthcare system considerations for GBS management. Ethical considerations encompass patient autonomy, resource allocation, and end-of-life decision-making.<\/jats:p>","DOI":"10.1097\/md.0000000000038890","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T14:20:34Z","timestamp":1722003634000},"page":"e38890","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Clinical presentation and symptomatology of Guillain-Barr\u00e9 syndrome: A literature review"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0249-1865","authenticated-orcid":false,"given":"Chukwuka","family":"Elendu","sequence":"first","affiliation":[{"name":"Federal University Teaching Hospital, Owerri, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella I.","family":"Osamuyi","sequence":"additional","affiliation":[{"name":"Bingham University Teaching Hospital, Jos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikeoluwa A.","family":"Afolayan","sequence":"additional","affiliation":[{"name":"Plateaumed Nigeria Limited, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnamdi C.","family":"Opara","sequence":"additional","affiliation":[{"name":"Imo State University, Owerri, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkeiruka A.","family":"Chinedu-Anunaso","sequence":"additional","affiliation":[{"name":"University of Nigeria Teaching Hospital, Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinonso B.","family":"Okoro","sequence":"additional","affiliation":[{"name":"University of Nigeria Teaching Hospital, Ituku-Ozalla, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine U.","family":"Nwankwo","sequence":"additional","affiliation":[{"name":"Federal University Teaching Hospital, Owerri, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne O.","family":"Ezidiegwu","sequence":"additional","affiliation":[{"name":"Nnamdi Azikiwe University Teaching Hospital Nnewi, Nnewi, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinweike A.","family":"Anunaso","sequence":"additional","affiliation":[{"name":"Alex Ekwueme Federal University Ndufu-Alike, Abakaliki, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins C.","family":"Ogbu","sequence":"additional","affiliation":[{"name":"University of Port Harcourt Teaching Hospital, Choba, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel O.","family":"Aghahowa","sequence":"additional","affiliation":[{"name":"Nigerian Navy Reference Hospital, Ojo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibuzor S.","family":"Atuchukwu","sequence":"additional","affiliation":[{"name":"Nnamdi Azikiwe University Teaching Hospital Nnewi, Nnewi, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everister U.","family":"Akpa","sequence":"additional","affiliation":[{"name":"Jos University Teaching Hospital, Jos, Nigeria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse C.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Federal University Teaching Hospital, Owerri, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250716","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-0039-1693005","article-title":"Guillain-Barre syndrome.","volume":"39","author":"Malek","year":"2019","journal-title":"Semin Neurol"},{"key":"R2-20250716","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-20250716","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis.","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R4-20250716","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-981-32-9636-7_20","article-title":"Guillain-Barr\u00e9 Syndrome.","volume":"1190","author":"Kaida","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"R5-20250716","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis.","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"R6-20250716","first-page":"565","article-title":"Criteria for diagnosis of Guillain-Barr\u00e9 syndrome.","volume":"3","author":"Asbury","year":"1978","journal-title":"Ann Neurol"},{"issue":"suppl","key":"R7-20250716","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome.","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"R8-20250716","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"R9-20250716","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome.","volume":"67","author":"Walgaard","year":"2010","journal-title":"Ann Neurol"},{"key":"R10-20250716","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00415-011-6330-4","article-title":"Guillain-Barr\u00e9 syndrome associated with normal or exaggerated tendon reflexes.","volume":"259","author":"Yuki","year":"2012","journal-title":"J Neurol"},{"key":"R11-20250716","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome.","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"issue":"pt 6","key":"R12-20250716","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","article-title":"An acute axonal form of Guillain-Barr\u00e9 polyneuropathy.","volume":"109 (Pt 6)","author":"Feasby","year":"1986","journal-title":"Brain"},{"key":"R13-20250716","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mus.22298","article-title":"Sensory Guillain-Barr\u00e9 syndrome and related disorders: an attempt at systematization.","volume":"45","author":"Uncini","year":"2012","journal-title":"Muscle Nerve"},{"key":"R14-20250716","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1529-8027.2009.00243.x","article-title":"Recurrences, vaccinations and long-term symptoms in GBS and CIDP.","volume":"14","author":"Kuitwaard","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"R15-20250716","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","article-title":"Mortality in Guillain-Barr\u00e9 syndrome.","volume":"80","author":"van den Berg","year":"2013","journal-title":"Neurology"},{"key":"R16-20250716","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group.","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"R17-20250716","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies.","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin Neurophysiol"},{"issue":"pt 1","key":"R18-20250716","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria.","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"R19-20250716","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-510X(77)90183-6","article-title":"The Landry-Guillain-Barr\u00e9 syndrome. Complications, prognosis and natural history in 123 cases.","volume":"33","author":"Loffel","year":"1977","journal-title":"J Neurol Sci"},{"key":"R20-20250716","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann Neurol"},{"key":"R21-20250716","doi-asserted-by":"crossref","first-page":"885897","DOI":"10.3389\/fneur.2022.885897","article-title":"Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barr\u00e9 syndrome.","volume":"13","author":"Pizzo","year":"2022","journal-title":"Front Neurol"},{"key":"R22-20250716","doi-asserted-by":"crossref","first-page":"509","DOI":"10.31083\/j.jin2002054","article-title":"On clinical findings of Bickerstaff\u2019s brainstem encephalitis in childhood.","volume":"20","author":"Messina","year":"2021","journal-title":"J Integr Neurosci"},{"key":"R23-20250716","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy.","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"R24-20250716","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barr\u00e9 syndrome.","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"R25-20250716","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis.","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine (Baltimore)"},{"key":"R26-20250716","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy.","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"issue":"pt 3","key":"R27-20250716","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain-Barr\u00e9 syndrome in northern China; the spectrum of neuropathological changes in clinically defined cases.","volume":"118 (Pt 3)","author":"Griffin","year":"1995","journal-title":"Brain"},{"key":"R28-20250716","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma.","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"R29-20250716","doi-asserted-by":"crossref","first-page":"e88703","DOI":"10.1371\/journal.pone.0088703","article-title":"Fc\u03b3 receptor-mediated inflammation inhibits axon regeneration.","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"R30-20250716","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","article-title":"Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barr\u00e9 syndrome.","volume":"192","author":"Chi","year":"2007","journal-title":"J Neuroimmunol"},{"key":"R31-20250716","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12026-014-8580-6","article-title":"Intravenous immunoglobulin exerts reciprocal regulation of Th1\/Th17 cells and regulatory T cells in Guillain-Barr\u00e9 syndrome patients.","volume":"60","author":"Maddur","year":"2014","journal-title":"Immunol Res"},{"key":"R32-20250716","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(02)00036-9","article-title":"Sialosyl-galactose: a common denominator of Guillain-Barr\u00e9 and related disorders.","volume":"196","author":"Moran","year":"2002","journal-title":"J Neurol Sci"},{"key":"R33-20250716","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/504294","article-title":"Incidence of Guillain-Barr\u00e9 syndrome among patients with Campylobacter infection: a general practice research database study.","volume":"194","author":"Tam","year":"2006","journal-title":"J Infect Dis"},{"key":"R34-20250716","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"R35-20250716","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","article-title":"Guillain-Barr\u00e9 syndrome associated with Zika virus infection in Colombia.","volume":"375","author":"Parra","year":"2016","journal-title":"N Engl J Med"},{"key":"R36-20250716","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol"},{"key":"R37-20250716","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2.","volume":"382","author":"Goscano","year":"2020","journal-title":"N Engl J Med"},{"key":"R38-20250716","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller Fisher syndrome and polyneuritis cranialis in COVID-19.","volume":"95","author":"Guti\u00e9rrez-Ortiz","year":"2020","journal-title":"Neurology"},{"key":"R39-20250716","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archneur.1968.00470350058005","article-title":"Idiopathic polyneuritis after surgery.","volume":"18","author":"Arnason","year":"1968","journal-title":"Arch Neurol"},{"key":"R40-20250716","doi-asserted-by":"crossref","first-page":"e1220","DOI":"10.1212\/WNL.0000000000006246","article-title":"Surgery and risk of Guillain-Barr\u00e9 syndrome: a French nationwide epidemiologic study.","volume":"91","author":"Rudant","year":"2018","journal-title":"Neurology"},{"key":"R41-20250716","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","article-title":"Guillain-Barr\u00e9 syndrome after exposure to influenza virus.","volume":"10","author":"Lehmann","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"pt 5","key":"R42-20250716","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"key":"R43-20250716","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1523\/JNEUROSCI.4926-14.2015","article-title":"Anti-ganglioside antibodies induce nodal and axonal injury via Fc\u03b3 receptor-mediated inflammation.","volume":"35","author":"He","year":"2015","journal-title":"J Neurosci"},{"key":"R44-20250716","doi-asserted-by":"crossref","first-page":"e0220250","DOI":"10.1371\/journal.pone.0220250","article-title":"Elimination of activating Fc\u03b3 receptors in spontaneous autoimmune peripheral polyneuropathy model protects from neuropathic disease.","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"key":"R45-20250716","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome.","volume":"19","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R46-20250716","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome.","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"R47-20250716","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 syndrome.","volume":"22","year":"1987","journal-title":"Ann Neurol"},{"key":"R48-20250716","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group.","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R49-20250716","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CND.0b013e3181f3dbbf","article-title":"Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barr\u00e9 syndrome: critical reassessment of effectiveness and cost-efficiency.","volume":"12","author":"Oczko-Walker","year":"2010","journal-title":"J Clin Neuromuscul Dis"},{"key":"R50-20250716","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2019-321496","article-title":"Original research: second IVIg course in Guillain-Barr\u00e9 syndrome with poor prognosis: the non-randomised ISID study.","volume":"91","author":"Verboon","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R51-20250716","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.21737","article-title":"Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barr\u00e9 syndrome.","volume":"66","author":"Kuitwaard","year":"2009","journal-title":"Ann Neurol"},{"key":"R52-20250716","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jnnp.64.2.242","article-title":"Risk factors for treatment related clinical fluctuations in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 study group.","volume":"64","author":"Visser","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R53-20250716","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barr\u00e9 syndrome: a randomized trial.","volume":"116","author":"Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"key":"R54-20250716","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/cc10305","article-title":"Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 syndrome: a randomized study.","volume":"15","author":"El-Bayoumi","year":"2011","journal-title":"Crit Care"},{"key":"R56-20250716","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial.","volume":"17","author":"Misawa","year":"2018","journal-title":"Lancet Neurol"},{"key":"R57-20250716","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1091581817740873","article-title":"Nonclinical development of ANX005: a humanized anti-C1q antibody for treatment of autoimmune and neurodegenerative diseases.","volume":"36","author":"Lansita","year":"2017","journal-title":"Int J Toxicol"},{"key":"R59-20250716","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-017-1730-x","article-title":"Modulation of IgG-FcRn interactions to overcome antibody-mediated inhibition of nerve regeneration.","volume":"134","author":"Zhang","year":"2017","journal-title":"Acta Neuropathol"},{"key":"R62-20250716","doi-asserted-by":"crossref","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R63-20250716","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.expneurol.2016.05.020","article-title":"Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury.","volume":"282","author":"Zhang","year":"2016","journal-title":"Exp Neurol"},{"issue":"Pt 10","key":"R64-20250716","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/awg233","article-title":"Bickerstaff\u2019s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barr\u00e9 syndrome.","volume":"126","author":"Odaka","year":"2003","journal-title":"Brain"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T23:00:43Z","timestamp":1752706843000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":60,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038890","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}